Evidence map›Paper›PMID 41898411›Full record

ArticleInternational journal of molecular sciences2026

Time-Course Evaluation of the In Vivo Resorption Process of Calcium Phosphates/Poly(lactide-

Shunsaku Takeishi, Kazuhiro Yasukawa, Maki Hiroshima, Chie Suzuki, Yasuhiro Magata

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shunsaku TakeishiResearch and Development Department, Teijin Medical Technologies Co., Ltd., Okayama 7011221, Japan.
Kazuhiro YasukawaResearch and Development Department, Teijin Medical Technologies Co., Ltd., Okayama 7011221, Japan.
Maki HiroshimaIn Vivo Imaging Office, Division of Preeminent Bioimaging Research, Institute of Photonics Medicine, Hamamatsu University School of Medicine, Hamamatsu 4313192, Japan.
Chie SuzukiMolecular Imaging Laboratory, Division of Preeminent Bioimaging Research, Institute of Photonics Medicine, Hamamatsu University School of Medicine, Hamamatsu 4313192, Japan.ORCID 0000-0002-7997-1955
Yasuhiro MagataMolecular Imaging Laboratory, Division of Preeminent Bioimaging Research, Institute of Photonics Medicine, Hamamatsu University School of Medicine, Hamamatsu 4313192, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There has been much development of composites of calcium phosphate and polymers for use as artificial bone, with other applications still ongoing, and clarification of the in vivo absorption mechanism is considered an important perspective. In order to clarify the absorption mechanism of bioabsorbable materials used for artificial bones and bone grafts, we prepared composites of calcium phosphate and polymers and conducted in vivo experiments in experimental animals using composites as implantation samples. Two typical types of calcium phosphate, β-tricalcium phosphate (β-TCP) and unsintered hydroxyapatite (uHA), were used as calcium phosphate, and copolymers of poly-dl-lactide-

Indexed as

Bone ResorptionBone SubstitutesCalcium PhosphatesLactic AcidPolyglactin 910Polyglycolic AcidAnimalsBiocompatible MaterialsDurapatitePolylactic Acid-Polyglycolic Acid CopolymerRabbitsbeta-tricalcium phosphateBiocompatible MaterialsBone SubstitutesCalcium PhosphatesDurapatiteLactic AcidPolyglactin 910Polyglycolic AcidPolylactic Acid-Polyglycolic Acid Copolymerbiodegradable polymersbiomaterialscalcium phosphatescellular and tissue responsecomposite materialsin vivomacrophagesPET/CT

Identifiers

PMID41898411
PMCPMC13026516

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.